Menu

Top Stories

Published on Tuesday, February 26, 2019

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

MIAMI, Feb. 26th, 2019 - The 7th Alpha-1 Global Patient Congress and 4th International Research Conference on Alpha-1 Antitrypsin will be held April 3-6, at the Sheraton Dubrovnik Riviera Hotel in Dubrovnik, Croatia. Patient leaders, physicians and scientists from around the world will come together to discuss the latest developments in patient advocacy, clinical care and Alpha-1 Antitrypsin Deficiency (Alpha-1) research. 

With a rich history of international collaboration, the Foundation is committed to Alphas worldwide and is proud to host representatives from 32 countries. Through the dedication of the Conference Planning Committee, we are looking forward to another outstanding event. The commitment to the mission drives the Alpha-1 Global program each day, to increase awareness, detection, and access to care for Alphas around the world.  

“The recent changes in the Alpha-1 Global program offers me the opportunity to reshape our outreach to the entire Alpha-1 community, globally. Our strategic alliances are strong and will be reaffirmed in Dubrovnik, Croatia, at our International Scientific Conference and concurrent International Patient Congress. I would like to extend my gratitude to the Internal Conference Planning Committee, Richard Lovrich, who will be our emcee, and the Foundation’s hardworking staff and volunteers,” expressed Miriam O’Day, president and CEO of the Alpha-1 Foundation.

“These events will be the first international meetings I have attended since our meeting in Barcelona, in 2013. This is an exciting opportunity to be able to collaborate and strategize about the future of the Global program in my new role as president and CEO,” she added.

The 2019 meeting will begin with the 4th International Research Conference on Wednesday and Thursday, April 3-4. The Research Conference theme titled “Beyond Folding: Disease Progression and Therapeutic Options” is chaired by Professor Rob Stockley from University Hospitals Birmingham, United Kingdom. 

The program agenda for the 4th International Research Conference is available to view here

We will continue with representatives from 32 countries at the Global Patient Congress with a welcome reception and networking dinner where Alpha-1 patients, physicians and researchers can interact on Thursday, April 4th. The patient congress will continue Friday and Saturday, April 5-6.

The program agenda for the 7th Alpha-1 Global Patient Congress is available to view here

A special thank you to our outstanding Global Conference Planning Committee and Global Advisory Committee:

  • Cristina Barbiero, National Association Alfa-1 AT Italy, EU Advocacy Working Group, Italy
  • Jim Clarke, Alpha-1 Association New Zealand Co-Leader Alpha-1 Support Group, New Zealand
  • Shane Fitch, Lovexair Foundation - President, Spain
  • Elena Goyanes, Alpha-1 Association Spain, EU Advocacy Working Group, Spain
  • Karen O'Hara, Alpha-1 UK Support Group - ERN - Lung, EARCO, UK
  • Carlos Cambon, Alpha-1 Association Argentina, Argentina  
  • Martina Cambon, Alpha-1 Association Argentina, Argentina
  • Frank Willersinn, MD, Alpha-1 Plus, Belgium
  • Marion Bouchecareilh, University of Bordeaux, Alpha-1 Liver Research, France
  • Robert Durlik, Alpha-1 Poland, Founder, Poland
  • Robert Kroesen, Patient Representative, Panama
  • Tim Frost, AlphaNet Board Member, USA

Global Advisory Committee: 

  • Jeanine D’Armiento, MD, PhD, Alpha-1 Foundation – Chair, USA
  • Robert Sandhaus, MD, PhD, FCCP, Alpha-1 Foundation Medical Director, USA
  • Robert Stockley, MD, Director Lung Immuno Biochemical Research Laboratory, UK
  • Adam Wanner, MD, Alpha-1 Foundation Scientific Director, USA

The Alpha-1 Foundation graciously thanks the 2019 Alpha-1 Global Patient Congress and Research Conference Sponsors. Presenting Sponsors: AlphaNet, CSL Behring and Grifols. Gold Sponsors: Arrowhead, Kamada and Vertex. Bronze Sponsors: Dicerna and Mereo BioPharma.

CLICK HERE TO REGISTER TODAY

For additional information on the upcoming events, please contact Randel Plant, global programs manager, rplant@alpha1.org or 877-228-7321 ext. 306.

For hotel and travel arrangements, please contact Adriana De Arce, manager of scientific events, adearce@alpha1.org or 877-228-7321 ext. 269.


Print

Gratitude and good wishes this holiday season to you, the foundation of our success

Tuesday, December 23, 2014
Because the goodwill of those we serve is the foundation of our success, it’s a pleasure at this holiday time to say thank you. We wish you a happy holiday season and a New Year of health, happiness and prosperity. Board...
Divider

FDA to lift lifetime ban on gay blood donors

Tuesday, December 23, 2014
The Food and Drug Administration announced on Tuesday that it would scrap a decades-old lifetime prohibition on blood donation by gay and bisexual men, a change that experts said was long overdue and could lift the annual blood supply by as much...
Divider

Foundation joins coalition urging House to support drug benefits

Monday, December 22, 2014
The Alpha-1 Foundation and COPD Foundation joined two dozen other organizations of the Medicare Access of Patients Rx (MAPRx) Coalition in writing to leaders of the U.S. House Committee on Energy and Commerce, urging support of Part D drug...
Divider

Alpha-1 Canada launches kids’ program with ‘Look At Us'

Monday, December 22, 2014
Just in time for the holidays, Alpha-1 Canada is launching its A-1 Kids Program to bring information, education and support to children with Alpha-1, their caregivers, family members and healthcare providers. Early intervention and education...
Divider

Happy Holidays from the Alpha-1 Foundation

Friday, December 19, 2014
Because the goodwill of those we serve is the foundation of our success, it’s a pleasure at this holiday time to say thank you. We wish you a happy holiday season and a New Year of health, happiness and prosperity. Board &...
Divider

Alpha Daryl Kunz draws strength from community, cycling

Friday, December 19, 2014
What if your passion preserved your life? Would you think about it differently, even to the point of making it a priority? For Daryl Kunz, whose passion for 20 years has been cycling, these questions are more than rhetorical musings. Every...
Divider

Alpha Daryl Kunz draws strength from community, cycling

Friday, December 19, 2014
What if your passion preserved your life? Would you think about it differently, even to the point of making it a priority? For Daryl Kunz, whose passion for 20 years has been cycling, these questions are more than rhetorical musings. Every...
Divider

Alpha-1 Foundation CEO John Walsh elected to NHC Board

Thursday, December 18, 2014
John Walsh, president and co-founder of the Alpha-1 Foundation, has been re-elected to the National Health Council‘s 2015 Board of Directors. Walsh served on the Board this year, and as NHC Board Chair in 2005-06. Read more about him...
Divider

‘Allergy & Asthma Today’ features article on Alpha-1

Wednesday, December 17, 2014
The Winter 2014 issue of Allergy & Asthma Today, the Allergy and Asthma Network (AANMA)'s quarterly magazine, features the article "How Alpha-1 Mimics Asthma and COPD," by Alpha-1 Foundation Communications Director Bob Campbell. He interviews...
Divider

National Health Council launches upgraded site to help with health insurance choices

Wednesday, December 17, 2014
The National Health Council has launched its newly upgraded website, PuttingPatientsFirst.net. The website gives people the tools to gain a better understanding of their options in the health insurance marketplace and find...
Divider

Study: E-cigarette use has overtaken smoking among youths

Wednesday, December 17, 2014
A new federal survey has found that electronic cigarette use among teenagers has surpassed the use of traditional cigarettes as smoking has continued to decline. Health advocates say the trend for e-cigarette use, or vaping, is dangerous because...
Divider

FDA OKs system that aims to make blood plasma donation safer, but experts have reservations

Wednesday, December 17, 2014
The Food and Drug Administration on Tuesday approved the first system that could be used by blood banks to destroy viruses and bacteria in donated blood plasma, potentially making transfusions safer. The system represents an extra safety step...
Divider
First54555657585960616263Last

Article Search

Enter keywords in text box and click Search button for results.

Archive